Longevity News

IgG glycosylation dynamics in active lupus nephritis during the first year of immunosuppressive therapy

Source: Frontiers - Health • Published: 18 Aug 2026, 00:00

IgG glycosylation dynamics in active lupus nephritis during the first year of immunosuppressive therapy

Report on longitudinal changes in IgG glycosylation in active lupus nephritis patients during the first year of immunosuppressive therapy, focusing on shifts from active to treated disease.

Key Takeaways
  • Is a severe manifestation of systemic lupus erythematosus (SLE)
  • SLE disproportionately affects women, with an estimated female-to-male prevalence ratio of approximately 9:1 ( 1 , 2 )
  • Each IgG molecule contains a conserved N-glycosylation site
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthToward nursing-integrated biomarker surveillance for immune-related adverse events during immune checkpoint inhibitor therapyDescribes nursing-integrated biomarker surveillance strategies to detect immune-related adverse events during immune checkpoint inhibitor therapy and how to operationalize them.Frontiers - HealthSpatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validationReview of how single-cell and spatial multi-omics map tumor and immune architectures in large B-cell lymphoma and guide pathology-ready biomarker development.Fight Aging!TIMP2 Protein Therapy Favorable Adjusts the Behavior of Microglia in the Aging BrainLooks at how restoring a youth-associated extracellular protein can shift aged microglia toward less inflammatory, more functional states in mice.Frontiers - HealthDeep learning-assisted near-real-time identification of the inferior mesenteric artery and vein during laparoscopic rectal resection: a single-center proof-of-concept studyA short research article about a deep-learning tool that labels key pelvic vessels in near-real-time to support safer laparoscopic rectal surgery.